Neuroactive steroids for the treatment of depression and anxiety: gaps and promises. [PDF]
Rupprecht R, Schüle C, Gudermann T.
europepmc +1 more source
Multi-Omics Integration and Causal Inference Identify HSD17B1 as a Potential Nobiletin Target Linking Neurosteroid Metabolism to Alzheimer's Disease. [PDF]
Gao R, Lyu C, Gu Y, Hao R, Wang C, Li X.
europepmc +1 more source
GABA<sub>A</sub> Receptor Modulators as Emerging Therapeutic Agents for Depressive Disorders. [PDF]
Guan BY, Li Y.
europepmc +1 more source
Neurosteroid modulators in psychiatric disorders: Emerging evidence and therapeutic implications. [PDF]
Deligiannidis KM.
europepmc +1 more source
The role of neuroactive steroids in psychiatric and neurological disorders: Neurobiology and therapeutic perspectives. [PDF]
Pinna G, Bortolato M.
europepmc +1 more source
Neurosteroids: a lifelong impact on brain health. [PDF]
Walton NL, Maguire JL.
europepmc +1 more source
Editorial: Molecular mechanisms in perinatal psychiatry. [PDF]
Pinna G, Pathak GA.
europepmc +1 more source
Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment. [PDF]
Chiappini S +10 more
europepmc +1 more source
Pregnanolone-Based Prodrugs as a Strategy for Neuroprotective Drug-Like Compounds: Pregnanolone Pyroglutamate and Its Age‑dependent Anticonvulsant Effects in the 6-hz Seizure Model in Immature Rats. [PDF]
Mareš P +4 more
europepmc +1 more source
Structure-activity relationships of steroid and sterol neuromodulators on inflammatory markers in a murine microglial cell line. [PDF]
Shu HJ +3 more
europepmc +1 more source

